- Home
- PRPO vs GROW Comparison
PRPO vs GROW Comparison
Compare PRPO & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRPO | GROW |
|---|---|---|
| Founded | N/A | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 33.0M |
| IPO Year | 2000 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PRPO | GROW |
|---|---|---|
| Price | $19.02 | $2.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 34.2K | 12.3K |
| Earning Date | 11-10-2026 | 11-16-2026 |
| Dividend Yield | N/A | ★ 3.35% |
| EPS Growth | 92.15 | ★ 900.00 |
| EPS | N/A | ★ 0.24 |
| Revenue | ★ $24,049,000.00 | $14,399,000.00 |
| Revenue This Year | $233.72 | N/A |
| Revenue Next Year | $22.61 | N/A |
| P/E Ratio | ★ N/A | $11.21 |
| Revenue Growth | 29.77 | ★ 32.77 |
| 52 Week Low | $17.79 | $2.23 |
| 52 Week High | $33.63 | $3.65 |
Technical Indicators
Market Signals| Indicator | PRPO | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 39.94 | 43.18 |
| Support Level | $19.37 | $2.49 |
| Resistance Level | $24.78 | $2.75 |
| Average True Range (ATR) | 1.01 | 0.09 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 37.67 | 63.64 |
Price Performance
Historical ComparisonAbout PRPO Precipio Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.